Rachel Wong

Title: Rachel Wong: Innovator in SARS-CoV-2 Testing

Introduction

Rachel Wong is a prominent inventor based in Tucson, AZ (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of SARS-CoV-2 antibodies. Her innovative work is crucial in the ongoing fight against the COVID-19 pandemic.

Latest Patents

Rachel Wong holds a patent for her invention titled "Serological assays for SARS-CoV-2." This patent includes a test system that comprises the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domain (RBD) antigen, SARS-CoV-2 S2 antigen, and binding moieties that specifically bind to human IgG, human IgA, and human IgM. The methods provided in her patent enable the detection of SARS-CoV-2 antibodies in a sample using this test system. She has 1 patent to her name.

Career Highlights

Rachel Wong is affiliated with The University of Arizona, where she continues her research and development in the field of virology and immunology. Her work is instrumental in advancing diagnostic techniques that can help manage and control viral outbreaks.

Collaborations

Rachel collaborates with esteemed colleagues such as Deepta Bhattacharya and Makiko Watanabe. Their combined expertise enhances the research efforts at The University of Arizona.

Conclusion

Rachel Wong's innovative contributions to SARS-CoV-2 testing exemplify the vital role of inventors in addressing global health challenges. Her work not only advances scientific knowledge but also provides practical solutions in the fight against infectious diseases.